• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,851.81 76.07
( 0.10%)
Global Indices
Nasdaq
51,069.65 379.68
(0.75%)
Dow Jones
7,605.10 20.47
(0.27%)
Hang Seng
66,385.32 1,692.20
(2.62%)
Nikkei 225
10,420.12 -5.84
(-0.06%)
Forex
USD-INR
95.93 0.16
(0.16%)
EUR-INR
111.54 0.10
(0.09%)
GBP-INR
128.71 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.17%)

EQUITY - MARKET SCREENER

ICICI Lombard General Insurance Company Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
540716
INE765G01017
333.5182228
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ICICIGI
32.23
89338.7
EPS(TTM)
Face Value()
Div & Yield %
55.58
10
0.75
 

Natco Pharma consolidated net profit declines 34.11% in the March 2026 quarter
May 30,2026
Net profit of Natco Pharma declined 34.11% to Rs 267.90 crore in the quarter ended March 2026 as against Rs 406.60 crore during the previous quarter ended March 2025. Sales declined 39.47% to Rs 739.10 crore in the quarter ended March 2026 as against Rs 1221.00 crore during the previous quarter ended March 2025.

For the full year,net profit declined 24.76% to Rs 1418.50 crore in the year ended March 2026 as against Rs 1885.40 crore during the previous year ended March 2025. Sales declined 7.93% to Rs 4078.30 crore in the year ended March 2026 as against Rs 4429.50 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales739.101221.00 -39 4078.304429.50 -8
OPM %17.2644.89 -35.2249.58 -
PBDT194.50604.20 -68 1697.402526.60 -33
PBT144.10505.90 -72 1490.802291.40 -35
NP267.90406.60 -34 1418.501885.40 -25